Recent Finacing
Recent Raise
Inventiva Pharma develops therapies for fibrotic and orphan diseases such as NASH, systemic scleroderma and MPS using a fibrosis-informed platform, 240k+ compound library, patient-cell models, and advancing lanifibranor and odiparcil.
